Related references
Note: Only part of the references are listed.Both human and mouse mesenchymal stem cells promote breast cancer metastasis
Stella Maris Albarenque et al.
STEM CELL RESEARCH (2011)
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer
T. Trarbach et al.
BRITISH JOURNAL OF CANCER (2010)
A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
D. Ross Camidge et al.
CLINICAL CANCER RESEARCH (2010)
TRAIL-Induced Apoptosis Is Preferentially Mediated via TRAIL Receptor 1 in Pancreatic Carcinoma Cells and Profoundly Enhanced by XIAP Inhibitors
Dominic Stadel et al.
CLINICAL CANCER RESEARCH (2010)
Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence
Jana Luetzkendorf et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5
Johannes Lemke et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis
Ling Zhang et al.
NATURE (2010)
Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell-Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells
Andrea Mohr et al.
STEM CELLS (2010)
Rapid and efficient cancer cell killing mediated by high-affinity death receptor homotrimerizing TRAIL variants
C. R. Reis et al.
CELL DEATH & DISEASE (2010)
Small Molecule XIAP Inhibitors Enhance TRAIL-Induced Apoptosis and Antitumor Activity in Preclinical Models of Pancreatic Carcinoma
Meike Vogler et al.
CANCER RESEARCH (2009)
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Michael R. Loebinger et al.
CANCER RESEARCH (2009)
Enhanced Antitumor Efficacy of a DR5-Specific TRAIL Variant over Recombinant Human TRAIL in a Bioluminescent Ovarian Cancer Xenograft Model
Evelien W. Duiker et al.
CLINICAL CANCER RESEARCH (2009)
TRAIL Gene Therapy: From Preclinical Development to Clinical Application
Thomas S. Griffith et al.
CURRENT GENE THERAPY (2009)
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Mark E. Davis
MOLECULAR PHARMACEUTICS (2009)
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
Laura S. Sasportas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Human Bone Marrow-Derived Mesenchymal Stromal Cells Expressing S-TRAIL as a Cellular Delivery Vehicle for Human Glioma Therapy
Lata G. Menon et al.
STEM CELLS (2009)
Gene Therapy Using TRAIL-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells against Intracranial Glioma
Seong Muk Kim et al.
CANCER RESEARCH (2008)
Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo
Meike Vogler et al.
CANCER RESEARCH (2008)
Death receptors as targets for anti-cancer therapy
Kerstin Papenfuss et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model
Andrea Mohr et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Ligand-based targeting of apoptosis in cancer: The potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL)
Avi Ashkenazi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release
A. Mohr et al.
ONCOGENE (2008)
The TRAIL apoptotic pathway in cancer onset, progression and therapy
Ricky W. Johnstone et al.
NATURE REVIEWS CANCER (2008)
Mesenchymal stem cells in cancer: Tumor-associated fibroblasts and cell-based delivery vehicles
Brett Hall et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Regulation of TRAIL-induced apoptosis by XIAP in pancreatic carcinoma cells
M. Vogler et al.
ONCOGENE (2007)
Constitutively activated nuclear factor-κB, but not induced NF-κB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells
Susanne J. Braeuer et al.
MOLECULAR CANCER RESEARCH (2006)
Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor
Almer M. van der Sloot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies
M MacFarlane et al.
CANCER RESEARCH (2005)
Prediction of water and metal binding sites and their affinities by using the Fold-X force field
JWH Schymkowitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mesenchymal stem cells: clinical applications and biological characterization
FP Barry et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential
A Peister et al.
BLOOD (2004)
AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression
A Mohr et al.
GENE THERAPY (2004)
The secretable form of trimeric TRAIL, a potent inducer of apoptosis
MH Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer
TK Oost et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs
TM Ganten et al.
CELL DEATH AND DIFFERENTIATION (2004)
Mechanisms of apoptosis induction by nucleoside analogs
D Sampath et al.
ONCOGENE (2003)
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
K Ichikawa et al.
NATURE MEDICINE (2001)
Isotype-dependent inhibition of tumor growth in vivo by monoclonal antibodies to death receptor 4
A Chuntharapai et al.
JOURNAL OF IMMUNOLOGY (2001)
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
MR Sprick et al.
IMMUNITY (2000)
Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis
SB Bratton et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
